News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
54 Results
54 Results
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
RECOVER researchers develop new tools to help identify Long COVID in youngest children
Researchers analyzed data from RECOVER’s pediatric observational study to better understand how Long COVID impacts infants, toddlers, and preschool-aged children.
Feature
RECOVER study identifies unique symptom patterns of Long COVID in young children
Findings from a recent RECOVER pediatric observational study show that the most common Long COVID symptoms experienced by children 0 to 5 years old can be different than those experienced by older children and adults.
News Release
R3 Seminar Recap: Understanding metformin use and Long COVID and ME/CFS following COVID-19 infection: Insights from two studies
A recent RECOVER Research Review (R3) Seminar held May 13 spotlighted research presented by Carolyn Bramante, MD, MPH (University of Minnesota) and Steve Johnson, PhD (University of Minnesota) exploring how metformin, a widely prescribed medication primarily used to manage type 2 diabetes, may help reduce the risk of Long COVID. The seminar also featured a presentation from Suzanne Vernon, PhD (Bateman Horne Center) on research examining the risk of developing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a COVID-19 infection.
R3 Seminar Recap
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
RECOVER Representatives help inform and raise awareness about RECOVER research
Patient, Caregiver, and Community Representatives inform RECOVER research, help connect the initiative with different communities, and share news about RECOVER studies.
Feature
RECOVER study examines how a person’s sex impacts Long COVID risk
A recent RECOVER study found that women had a 31% higher risk for developing Long COVID than men. Findings from this study may help identify who is at a higher risk for developing Long COVID and potential Long COVID treatments.
Feature
RECOVER Representatives inform Long COVID research through authorship
Over the last two years, RECOVER Patient, Caregiver, and Community Representatives have helped plan and write more than 100 publications about RECOVER’s Long COVID research and its findings.
Feature